Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Van Dam PJ"'
Autor:
Van Dam, PJ
Background: Currently there is limited information available on how to support leadership learning in the clinical setting. Many of the cultural issues associated with organisational systems failure are believed to be associated with a lack of clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52104cde2726de214e80e9f2cba0a463
Autor:
Laere, B, Rajan, P, Gronberg, H, Dirix, L, Lindberg, J, Mayrhofer, M, Whitington, T, van Dam, PJ, Van Oyen, P, Ghysel, C, Ampe, J, Ost, P, Demey, W, Hoela, L, Schrijvers, D, Brouwers, B, Lybaert, W, Everaert, E, De Maeseneer, D, Strijbos, M, Bols, A, Fransis, K, Beije, Nick, Kruijff, I (Ineke), Dam, V, Brouwer, A, Goossens, D, Heyrman, L, Van den Eynden, G, Rutten, A, Del Favero, J, Rantalainen, M, Sleijfer, Stefan, Ullen, A, Yachnin, J, van Laere, S, De Laere, L, Develter, T, Vantieghem, S, Herman, S, Coifs, G, Lamotte, V, Boumans, A, Baitar, A, Haeck, R, Wallays, G
Publikováno v:
JAMA Oncology, 5(7), 1059-1061. American Medical Association
JAMA ONCOLOGY
JAMA ONCOLOGY
This post hoc analysis of a multi-institution cohort study assesses the association between androgen receptor perturbation and poorer outcome in patients with TP53 wild-type metastatic castration-resistant prostate cancer who are receiving abirateron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b6f2104ba0f57f83c371eb07934c16
https://doi.org/10.1001/jamaoncol.2019.0869
https://doi.org/10.1001/jamaoncol.2019.0869
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dinh TTH; School of Nursing, University of Tasmania, Newnham Campus, Newnham Drive, Newnham, Launceston, Tasmania 7248, Australia., Lees DB; School of Nursing, University of Tasmania, Newnham Campus, Newnham Drive, Newnham, Launceston, Tasmania 7248, Australia., Van Dam PJ; School of Nursing, University of Tasmania, Domain Campus, 71 Brooker Avenue, Glebe, Hobart, Tasmania 7001, Australia., McGarry DE; School of Nursing, University of Tasmania, Rozelle Campus, Corner of Church and Glover streets, Lilyfield, NSW 2039, Australia.
Publikováno v:
Health education research [Health Educ Res] 2024 Jul 18; Vol. 39 (4), pp. 351-374.
Autor:
Muilwijk T; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Organ Systems, KU Leuven, Leuven, Belgium., Baekelandt L; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Organ Systems, KU Leuven, Leuven, Belgium., Akand M; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Organ Systems, KU Leuven, Leuven, Belgium., Daelemans S; Pathology - Histology, Imaging and Quantification, CellCarta, Antwerp, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Marien K; Pathology - Histology, Imaging and Quantification, CellCarta, Antwerp, Belgium., Waumans Y; Pathology - Histology, Imaging and Quantification, CellCarta, Antwerp, Belgium., van Dam PJ; Pathology - Histology, Imaging and Quantification, CellCarta, Antwerp, Belgium., Kockx M; Pathology - Histology, Imaging and Quantification, CellCarta, Antwerp, Belgium., Van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Van Cleynenbreugel B; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Van der Aa F; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Organ Systems, KU Leuven, Leuven, Belgium., Gevaert T; Organ Systems, KU Leuven, Leuven, Belgium.; Department of Pathology, AZ Klina, Brasschaat, Belgium., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Organ Systems, KU Leuven, Leuven, Belgium.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Jul 01; Vol. 66, pp. 67-74. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk., Kockx M; HistogeneX N.V, Wilrijk, Belgium., Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gravis G; Institut Paoli-Calmettes, Marseille, France., Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain., Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK., Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France., Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France., Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Linch M; Department of Medical Oncology, University College London Hospital, London, UK., Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., van Dam PJ; HistogeneX N.V, Wilrijk, Belgium., Stanoeva D; HistogeneX N.V, Wilrijk, Belgium., Daelemans S; HistogeneX N.V, Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Mariathasan S; Genentech, San Francisco, CA, USA., Tea JS; Genentech, San Francisco, CA, USA., Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Banchereau R; Genentech, San Francisco, CA, USA., Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publikováno v:
Nature medicine [Nat Med] 2023 Dec; Vol. 29 (12), pp. 3271.